哌甲酯与托莫西汀对果蝇脑单细胞水平的影响及ADHD药物重定位潜力
该研究在果蝇中建立单细胞分辨率流程,同时检测行为与转录响应;哌甲酯和托莫西汀均引起神经元与胶质细胞反应,但哌甲酯在多种细胞类型中转录抑制效应更强,并提供了ADHD药物重定位的候选靶基因资源。
要点
- 哌甲酯和托莫西汀均使果蝇神经元和胶质细胞发生转录响应。
- 哌甲酯在多种细胞类型中抑制神经递质受体和突触信号基因的效应强于托莫西汀。
- 研究提供候选靶基因列表ADHDrug,支持药物重定位探索。
核心结论
- 哌甲酯和托莫西汀在果蝇脑单细胞水平引起 distinct 转录变化,哌甲酯对多种神经递质系统相关基因的抑制效应更强。
- 研究建立的流程可快速、经济地探索ADHD药物分子机制并促进药物重定位。
研究设计与样本
- 研究使用果蝇,经EasyFlyTracker筛选出与对照相比运动活性显著增加(类多动行为)的个体。
- 对82,917个细胞进行单细胞RNA测序,无监督聚类得到28个原代细胞簇,代表成年果蝇脑主要细胞类型。
- 对照食物与给药组食物相同,含5%蔗糖、酵母和蓝色食用色素溶液。
主要发现
- 神经元和胶质细胞均对哌甲酯和托莫西汀产生响应。
- 两个多巴胺受体基因Dop2R和DopEcR在最佳剂量下对哌甲酯响应,对托莫西汀不响应。
- 多巴胺代谢通路相关基因Syt1、Sytalpha、Syt7和Ih在不同细胞类型中发生变化。
- 哌甲酯在许多细胞类型中抑制其他神经递质受体和突触信号分子基因表达,尤其Glu和GABA相关基因,托莫西汀效应较弱。
- 鉴定出四种响应两种药物的胶质细胞亚型,与ensheathing和astrocyte-like胶质相关的差异表达基因较多。
关键数值与推荐
- 药物集富集分析支持候选靶基因资源,P = 2.10E-4(超几何检验)。
- 候选靶基因完整列表见ADHDrug(http://adhdrug.cibr.ac.cn/)。
临床怎么用
- 该果蝇单细胞流程可用于ADHD药物分子机制探索和药物重定位候选筛选。
- 哌甲酯与托莫西汀的转录效应差异提示两者对神经元和胶质细胞的作用不完全相同。
局限性
- 研究为果蝇模型,结果向人类临床转化的适用性需进一步验证。
- 单细胞转录组反映的是转录响应,未直接证明蛋白质功能或临床疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The stimulant methylphenidate (MPH) and the non-stimulant atomoxetine (ATX) are frequently used for the treatment of attention-deficit/hyperactivity disorder (ADHD); however, the function of these drugs in different types of brain cells and their effects on related genes remain largely unknown. To address these questions, we built a pipeline for the simultaneous examination of the activity behavior and transcriptional responses of Drosophila melanogaster at single-cell resolution following drug treatment. We selected the Drosophila with significantly increased locomotor activities (hyperactivity-like behavior) following the administration of each drug in comparison with the control (same food as the drug-treated groups with 5% sucrose, yeast, and blue food dye solution) using EasyFlyTracker. Subsequently, single cell RNA sequencing (scRNASEQ) was used to capture the transcriptome of 82,917 cells, unsupervised clustering analysis of which yielded 28 primary cell clusters representing the major cell types in adult Drosophila brain. Indeed, both neuronal and glial cells responded to MPH and ATX. Further analysis of differentially expressed genes (DEGs) revealed distinct transcriptional changes associated with these two drugs, such as two well-studied dopamine receptor genes (Dop2R and DopEcR) were responsive to MPH but not to ATX at their optimal doses, in addition to genes involved in dopamine metabolism pathways such as Syt1, Sytalpha, Syt7, and Ih in different cell types. More importantly, MPH also suppressed the expression of genes encoding other neurotransmitter receptors and synaptic signaling molecules in many cell types, especially those for Glu and GABA, while the responsive effects of ATX were much weaker. In addition to monoaminergic neuronal transmitters, other neurotransmitters have also shown a similar pattern with respect to a stronger effect associated with MPH than with ATX. Moreover, we identified four distinct glial cell subtypes responsive to the two drugs and detected a greater number of differentially expressed genes associated with ensheathing and astrocyte-like glia. Furthermore, our study provides a rich resource of candidate target genes, supported by drug set enrichment analysis (P = 2.10E-4; hypergeometric test), for the further exploration of drug repurposing. The whole list of candidates can be found at ADHDrug ( http://adhdrug.cibr.ac.cn/ ). In conclusion, we propose a fast and cost-efficient pipeline to explore the underlying molecular mechanisms of ADHD drug treatment in Drosophila brain at single-cell resolution, which may further facilitate drug repurposing applications.
引用
- Qu S, Zhou X, Wang Z, et al. The effects of methylphenidate and atomoxetine on Drosophila brain at single-cell resolution and potential drug repurposing for ADHD treatment. Mol Psychiatry. 2023. PMID: 37957291. doi:10.1038/s41380-023-02314-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。